Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rohto Hydra in Healthy and Dry Eye Patients
NCT02985827Phase 4Completed
- Start
- Dec 2015
- Primary completion
- Jan 2016
- Modality
- Polymer-based Nanoparticles, Small Molecules
01
Overview
Phase 4, single-blind trial of Rohto Hydra in dry eye disease (DED) (2 arms). Primary endpoint: Sum of the Cooling Scale For Rohto Hydra at 4 minutes. Started Dec 2015; status: completed.
02
Drugs
Rohto Hydra
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT02985827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02985827.